NCT00993343View on ClinicalTrials.gov

Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation

PHASE3CompletedINTERVENTIONAL

Enrollment

215

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 28, 2015

Study Completion Date

April 30, 2015

Conditions

Graft-versus-host DiseaseSurvival

Interventions

DRUG

Sirolimus/tacrolimus

Standard GVHD prophylaxis

DRUG

cyclosporine/methotrexate

Standard GVHD prophylaxis

Trial Locations (1)

14186

Karolinska University Hospital, Stockholm

All Listed Sponsors

lead

Karolinska Institutet

OTHER

NCT00993343 - Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter